Additionally, an increasing number of malignancies have more complex treatment regimens relevant to a broader population, for example chemoimmunotherapy in lung cancers regardless of PD-L1 status [20] or multi-agent chemotherapy as standard of care first line treatment in many pancreatic cancers [22]. The gene discussed is CD274; the disease is familial pancreatic carcinoma.